Skip to main content

Halozyme Therapeutic (NQ: HALO )

48.47 +0.68 (+1.42%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
April 20, 2008
Form DEF 14A
Source: SEC/Edgar
April 02, 2008
Form ARS
Source: SEC/Edgar
April 02, 2008
Form SC 13D/A
Source: SEC/Edgar
March 23, 2008
Form 8-K
Source: SEC/Edgar
March 18, 2008
Form 8-K
Source: SEC/Edgar
March 16, 2008
Form 8-K
Source: SEC/Edgar
February 11, 2008
Form 8-K
Source: SEC/Edgar
February 07, 2008
Form SC 13G/A
Source: SEC/Edgar
February 06, 2008
Form SC 13G/A
Source: SEC/Edgar
January 30, 2008
Form RW
Source: SEC/Edgar
December 20, 2007
Form 8-K
Source: SEC/Edgar
December 19, 2007
Form RW
Source: SEC/Edgar
December 18, 2007
Form 8-K
Source: SEC/Edgar
November 19, 2007
Form 8-A12B/A
Source: SEC/Edgar
November 19, 2007
Form SC 13D/A
Source: SEC/Edgar
November 14, 2007
Form 8-K
Source: SEC/Edgar
November 13, 2007
Form 8-K
Source: SEC/Edgar
November 08, 2007
Form DEF 14A
Source: SEC/Edgar
October 10, 2007
Form 15-12G
Source: SEC/Edgar
September 27, 2007
Form PRE 14A
Source: SEC/Edgar
September 25, 2007
Form 8-K
Source: SEC/Edgar
September 11, 2007
Form 8-K
Source: SEC/Edgar
August 20, 2007
Form 8-K
Source: SEC/Edgar
August 09, 2007
Form 8-K
Source: SEC/Edgar
July 30, 2007
Form 8-K
Source: SEC/Edgar
July 08, 2007
Form SC 13D/A
Source: SEC/Edgar
June 04, 2007
Form 8-K
Source: SEC/Edgar
May 31, 2007
Form 8-K
Source: SEC/Edgar
May 23, 2007
Form SC 13D
Source: SEC/Edgar
May 23, 2007
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.